Hensen'S Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Hensen's cells are specialized supporting epithelial cells located in the organ of Corti in the cochlea. They are the most lateral cells of the organ of Corti, bordering the outer sulcus and Hensen's stripe. These cells play important roles in cochlear mechanics, ion homeostasis, and have been implicated in hearing loss associated with neurodegenerative diseases.
| Taxonomy |
ID |
Name / Label |
| Cell Ontology (CL) |
CL:0000633 |
Hensen cell |
| Database |
ID |
Name |
Confidence |
| Cell Ontology |
CL:0000633 |
Hensen cell |
Exact |
Hensen's cells are columnar supporting epithelial cells with distinctive features:
- Vimentin — Intermediate filament (cytoskeletal)
- Cytokeratins — Epithelial markers (K8, K18)
- AQP1 — Aquaporin 1 (water channel)
- Na+/K+-ATPase — Ion pump subunits
- Connexin 26 (GJB2) — Gap junction protein
- prestin (SLC26A5) — Electromotility protein (in Deiters', but related)
- Organ of Corti architecture: Maintain structural integrity of cochlear duct
- Tectorial membrane interaction: Support and position the tectorial membrane
- Basilar membrane attachment: Provide lateral support for hair cells
- Endolymph homeostasis: Maintain high K+ in scala media
- Potassium recycling: K+ buffering and removal from outer hair cells
- Calcium regulation: Calcium homeostasis in cochlear fluids
- Cochlear amplification: Contribute to outer hair cell function
- Frequency tuning: Region-specific mechanical properties
- Passive vibration: Support basilar membrane movement
- Metabolic atrophy: Loss of Hensen's cell function
- Strial changes: Related to ion homeostasis
- Cochlear degeneration: Progressive hair cell loss
- Mechanical damage: Overstrain of supporting cells
- Metabolic exhaustion: Ion imbalance
- Excitotoxicity: Glutamate toxicity
- Aminoglycosides: Accumulation in supporting cells
- Loop diuretics: Disrupt ion transport
- Chemotherapy: Cisplatin-induced damage
- Auditory processing deficits: Beyond pure tone hearing loss
- Temporal processing: Speech in noise difficulties
- Cochlear pathology: Possible cochlear β-amyloid deposition
- Auditory deficits: Subtle hearing changes
- Speech perception: Difficulty with speech in noise
- Brainstem auditory pathways: Lewy body involvement
- Auditory brainstem dysfunction: ABR abnormalities
- Cochlear involvement: Possible hair cell loss
- Speech processing: Bulbar involvement
Gene expression studies show:
- Structural proteins: Vimentin, Cytokeratins
- Ion channels: KCNQ1, KCNE1, AQP1
- Gap junctions: GJB2, GJB6
- Transporters: SLC26A4 (pendrin), ATP1A3
- Intratympanic injections: Target inner ear structures
- Nanoparticle delivery: Targeted to supporting cells
- Gene therapy: GJB2 gene therapy potential
- Antioxidants: Reduce oxidative stress
- Anti-apoptotic agents: Prevent cell death
- Neurotrophic factors: Support hair cell survival
- Stem cell therapy: Replace lost supporting cells
- Hair cell regeneration: Supporting cell dedifferentiation
- Biomarkers: Early hearing loss detection
The study of Hensen'S Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.